Skip to content

Coaxial Bipolar Pacing Electrode

by Burditt & Calkins-Siemens-Elema

510(k) K822239

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK822239 Date4 Oct 1982ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a Permanent Pacemaker Electrode, classified under FDA regulation 870.3680, designed to deliver electrical pacing stimuli to the heart. Its coaxial bipolar configuration enables precise impulse transmission for cardiac rhythm management, ensuring stable pacing support in patients requiring temporary or permanent cardiac pacing.

The Coaxial Bipolar Pacing Electrode is intended for use in cardiac procedures, supplied as a sterile, single-use device for direct implantation. It is regulated under FDA 510(k) clearance (K822239) and falls under Class 3 medical device classification. Compatible with external pacemaker pulse generators, it is distributed in sterile packaging for immediate clinical application.

Other devices from Burditt & Calkins-Siemens-Elema

See all devices from Burditt & Calkins-Siemens-Elema →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of cardiac procedures is this coaxial bipolar pacing electrode designed for, and how is it used in those settings?

    This device is specifically designed for cardiac rhythm management procedures requiring precise electrical pacing. It is intended for direct implantation in patients who need temporary or permanent cardiac pacing support, such as those with bradycardia or other conduction disorders. The coaxial bipolar configuration ensures stable and accurate impulse transmission to the heart, making it suitable for use with external pacemaker pulse generators during or after implantation.

  • Is this pacing electrode single-use or reusable, and how should it be stored before use?

    The coaxial bipolar pacing electrode is supplied as a sterile, single-use device, meaning it is intended for one-time clinical application only. It comes in sterile packaging for immediate use, so storage should be kept in a clean, dry environment away from direct sunlight or extreme temperatures until ready for deployment. Always follow manufacturer guidelines for packaging integrity to ensure sterility is maintained.

  • What regulatory pathway was followed for this device’s approval, and what class does it fall under?

    This device was cleared through the FDA 510(k) pathway under the traditional review process, with a decision classification of *Substantially Equivalent* (SESE). It is classified as a Class 3 medical device under FDA regulation 870.3680, reflecting its role in life-sustaining or life-supporting functions. The clearance number is K822239, and it was reviewed by the Cardiovascular (CV) Advisory Committee.

  • How is this electrode compatible with other medical devices, and what should clinicians verify before use?

    The coaxial bipolar pacing electrode is designed to be compatible with external pacemaker pulse generators for delivering electrical pacing stimuli. Clinicians should verify compatibility with their specific pulse generator model to ensure proper function and safety. Since it is single-use and sterile, no additional sterilization or reprocessing is required—only proper handling and adherence to sterile technique during implantation.